Gene expression-based high-throughput screening (HTS)
In drug discovery, time is money. Fast-track your discovery using the QuantiGene Singleplex HT Assay, which enables gene expression-based high-throughput screening of thousands of compounds every day. The assay's ELISA-like workflow is easy to automate and does not require RNA purification or extensive assay optimization. The extremely robust QuantiGene Singleplex HT Assay is hybridization-based and uses no enzymes; instead, it relies on branched DNA technology for signal amplification and luminescence for signal readout.
- Quantitate a variety of samples: including cultured cells, whole blood, dried blood spots, fresh/frozen or FFPE samples, bacteria and purified RNA/DNA.
- High throughput: simple ELISA-like workflow is easily automated with liquid handling and dispensing platforms, with no RNA purification needed.
- Robust and reproducible: high Z'-factors are typically attained with the QuantiGene Singleplex HT Assay, giving you more confidence in your hits.
- Easy to use: no optimization of probe sets is required, sample preparation is minimal, and 384-well plate format allows for direct transfer of cells cultured in 384-well plates.
For Research Use Only. Not for use in diagnostic procedures.